Loading…
Held by equity mutual funds in 109 disclosed months, Jan 2013 to Sep 2026.
AstraZeneca Pharma India Limited (Pharmaceuticals & Biotechnology) was held by 20 active equity mutual funds in September 2026, ₹627 Cr in all (down 1 fund from Aug 2026). The largest position was Baroda BNP Paribas Health and Wellness Fund at 2.8% of its portfolio. During the month 1 fund entered and 2 exited. Funds have disclosed holding it since Jan 2013.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
How many equity funds held the company each month, and the value they held.